Moderna, Inc. is a Cambridge, Massachusetts-based biotechnology company that is focused on drug discovery and drug development based on messenger RNA (mRNA). The company creates synthetic mRNA that can be injected into patients to help them create their own therapies.
Click to see more
Moderna, Inc. Details
Operating Status:Active
Business TypePublic
HeadquartersCambridge, Massachusetts, United States
Moderna (MRNA) stock recently plunged over reported disagreements with government scientists about the company’s vaccine trial process. Today in the pre-market, the stock price is around $60.90.
Inovio has secured funding from the U.S Department of Defense to expedite the development and production of its Cellectra 3PSP Smart Devices for the administration of the COVID-19 vaccine. INO stock is up.
Following Moderna CEO’s big expectations on mRNA-1273 distribution, Moderna shares jumped. On June 18, Moderna stock rose by 2.59% to close at $64.95. In pre-market today, Moderna shares are 0.08% up.
At Coinspeaker we use cookies in order to improve site performance, offer you a better browsing experience and enable you to easily share content.AcceptPrivacy policy
